Oxford Immunotec
(OXFD)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 77,246 | 90,332 | 67,743 | 36,713 | 43,133 |
| Receivables | 16,900 | 6,021 | 21,652 | 18,016 | 16,906 |
| Inventories | 10,909 | 7,137 | 9,174 | 9,480 | 8,307 |
| Other current assets | 0 | 14,281 | 0 | 0 | 0 |
| TOTAL | $109,623 | $120,482 | $101,716 | $67,116 | $72,220 |
| Non-Current Assets | |||||
| PPE Net | 9,239 | 2,764 | 8,927 | 8,786 | 8,299 |
| Intangibles | 11,656 | 3,519 | 12,263 | 14,377 | 14,586 |
| Other Non-Current Assets | 3,299 | 17,471 | 14,085 | 22,648 | 19,161 |
| TOTAL | $24,194 | $23,754 | $35,275 | $45,811 | $42,046 |
| Total Assets | $133,817 | $144,236 | $136,991 | $112,927 | $114,266 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 93 | N/A | 89 | N/A | N/A |
| Accounts payable and accrued liabilities | 6,323 | 5,630 | 3,141 | 3,961 | 3,754 |
| Accrued Expenses | 8,564 | 7,807 | 15,563 | 15,734 | 13,120 |
| Other current liabilities | 4,581 | 8,972 | 2,396 | 3,197 | 1,118 |
| TOTAL | $19,593 | $22,445 | $21,534 | $22,935 | $18,040 |
| Non-Current Liabilities | |||||
| Long Term Debt | 30,020 | 29,856 | 29,787 | 29,670 | 29,552 |
| Deferred Revenues | 32 | 36 | 345 | 43 | 48 |
| Other Non-Current Liabilities | 4,592 | 4,306 | 8,294 | 7,836 | 364 |
| TOTAL | $34,612 | $34,162 | $38,081 | $37,506 | $29,916 |
| Total Liabilities | $54,205 | $56,607 | $59,615 | $60,441 | $47,956 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 25,881 | 25,872 | 25,655 | 23,076 | 22,927 |
| Common Shares | 271 | 269 | 269 | 247 | 244 |
| Retained earnings | -211,867 | -201,541 | -210,341 | -193,494 | -176,728 |
| Other shareholders' equity | -5,155 | -5,712 | -5,511 | -6,256 | -7,532 |
| TOTAL | $79,612 | $87,629 | $77,376 | $52,486 | $66,310 |
| Total Liabilities And Equity | $133,817 | $144,236 | $136,991 | $112,927 | $114,266 |